LifeStance Health Group, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.1B | $859.5M | $667.5M |
| Operating income | $24.1M | -$31.6M | -$189.1M | -$210.2M | -$286.4M |
| Operating expenses | $1.4B | $1.3B | $1.2B | $1.1B | $953.9M |
| Cash from operations | $146.2M | $107.3M | -$16.9M | $52.8M | $9.4M |
| Capital expenditure | $36.1M | $21.6M | $40.5M | $79.3M | $94.5M |
| Free cash flow | $110.0M | $85.7M | -$57.4M | -$26.5M | -$85.1M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $2.2B | $2.1B | $2.1B | $2.2B | $1.9B |
| Total liabilities | $682.9M | $672.0M | $681.0M | $655.1M | $382.1M |
| Total debt | — | $279.8M | $280.3M | $225.1M | $157.4M |
Shares outstanding 387.8M · Free float 44.0%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.